Sanofi-aventis Revenue and Competitors
Estimated Revenue & Valuation
- Sanofi-aventis's estimated annual revenue is currently $41.6M per year.
- Sanofi-aventis's estimated revenue per employee is $231,150
Employee Data
- Sanofi-aventis has 180 Employees.
- Sanofi-aventis grew their employee count by 5% last year.
Sanofi-aventis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Medical Director | Reveal Email/Phone |
2 | Strategy and Partnering, Director Digital Alliances | Reveal Email/Phone |
3 | Senior Manager - MSAT | Reveal Email/Phone |
4 | KSOL NA/LATAM | Reveal Email/Phone |
5 | Senior Partner | Reveal Email/Phone |
6 | Medical portfolio management | Reveal Email/Phone |
7 | Senior Associate, Regulatory Operations | Reveal Email/Phone |
8 | Scientist | Reveal Email/Phone |
9 | Lab Head/Distinguished Scientist | Reveal Email/Phone |
10 | Senior Medical Science Liaison | Reveal Email/Phone |
Sanofi-aventis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 27 | 29% | N/A | N/A |
#2 | $35.8M | 156 | 6% | N/A | N/A |
#3 | $5.4M | 27 | 23% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 72 | 50% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 45 | 15% | N/A | N/A |
#8 | $10.3M | 63 | 34% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Sanofi-aventis?
Sanofi-Aventis U.S. LLC is a pharmaceuticals company based out of 55 Corporate Dr, Bridgewater, New Jersey, United States.
keywords:N/A
N/A
Total Funding
180
Number of Employees
$41.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sanofi-aventis News
2022-04-20 - Artesunate Tablet Market Growth and Demands Analysis from ...
Artesunate Tablet Market Growth and Demands Analysis from 2022-2028 | Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis.
2022-04-19 - Global Biopharmaceuticals Market 2022 Business ...
Roche; Amgen; AbbVie; Sanofi-Aventis; Johnson & Johnson; Pfizer; Novo Nordisk; Eli Lilly; Novartis; Merck; Sun; 3sbio; Changchun High Tech...
2022-03-30 - Sanofi-aventis Reports Expanded Approval Of Dupixent In Canada To Include
Children Aged Six To 11
(RTTNews) - Sanofi-aventis Canada Inc. announced the expanded approval of Dupixent as an add-on maintenance treatment in patients aged six...
Other Companies in Bridgewater
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $29.8M | 187 | 63% | N/A |
#2 | $61.6M | 203 | 3% | N/A |
#3 | $61.8M | 224 | -5% | N/A |
#4 | $102.9M | 229 | 0% | N/A |
#5 | $58M | 231 | -5% | N/A |